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Abstract
Bovine immunodeficiency virus (BIV) is a bovine lentivirus that infects animals world-wide.
The authors have cloned the BIV env and gag proteins and several sub-unit peptides spanning the
entire coding regions of the two proteins as fusions to the bacterial trpE protein and expressed
them in Escherichia coli (Spindler et al. 1984). These recombinant proteins can readily be
expressed but the expression levels of these peptides varied. When these proteins were tested
against a panel of bovine sera, only sera from BIV-infected animals reacted specifically. One
major antigenic determinant was identified in the cartoxyl terminus of the p26 gag protein and
another was identified in the transmembrane (TM) domain of the envelope glycoprotein.
The pathogenesis of the BIV infection has not been well characterised. Experimentally-infected
animals did not develop immunodeficiency. It is possible that co-factors may playa role in
enhancing the pathogenesis of BIV infection; and one of these co-factors could be bovine herpes-
viruses (BHV). BHV-1 co-infection of BIV-infected cells enhanced BIV replication and an
immediate early gene of BHV-1 is involved. This herpes-viral gene product acts on the BIV pro-
motor element to stimulate BIV expression. In vivo co-infection of animals with BIV and BIV-1
demonstrated that these viruses can interact in vivo, with BHV-l reactivated BIV expression in
infected animals.
BOVINE immunodeficiency virus (BIV) is a lenti-
virus, originally isolated from cattle with lympho-
cytosis, lymphadenopathy, neuropathy and
progressive emaciation (Gonda 1992; Van Der
Maaten et a1. 1972). However, overt clinical disease
in seropositive cattle is rare and the infection is dif-
ficult to reproduce experimentally (Carpenter et a1.
1992; Flaming et al. 1993; Suarez et a1. 1993; Whet-
stone et a1. 1972). BIV antibodies have been detected
in beef and dairy cattle in the USA, some European
countries, Australia and New Zealand (Amborski et
a1. 1989, Horner 1991; Horzinek et a1. 1991; St. Cyr
Coats et a1. 1994; Whetsone et a1. 1991). However,
serological screening of randomly-selected cattle
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sera for BIV antibody has shown a non-uniform dis-
tribution. Sera from eastern or northern parts of the
USA are rarely positive for BIV, while approxi-
mately 4% of the sera from southern and south-
western regions are BIV positive (Black 1990) and
average frequencies with individual herds in the
south are considerably higher. For example, 40% of
beef and 60% of dairy herds were found to be
positive in Louisiana (Gonda 1994), and the sera-
prevalence of BIV among cattle herds in Mississippi
was greater than 50% (St. Cyr Coats et a1. 1994).
To screen for naturally-infected cattle, different
serological approaches have been employed,
including immunofluorescence assays (IFA) ,
Western blot assay (Whetstone et a1. 1972, 1991) and
enzyme linked immunosorbant assay (ELISA) (St.
Cyr Coats et a1. 1994). Although these tests were
able to detect BIV antibodies using BIV antigen or
BIV-infected cells, they lacked sensitivities and
required a large mount of native viral antigens. Since
BIV can only be propagated well in primary bovine
cell cultures and there is a lack of a continuous cell
line expressing high levels of BIV, the use of native
viral proteins for large scale serological testing of
BIV is quite difficult. In addition, the IFA and
ELISA tests can yield false positive results as com-
pared with Western blot assay (Atkinson et a1. 1992).
Therefore, there is a need to use recombinant
proteins as a source of antigens. Recombinant BIV
proteins have been expressed both in bacterial, insect
cells and eukaryotic cells (Rasmussen et a1. 1990),
and the bacterial recombinant gag and env proteins
have been used to detect anti-BIV antibodies by
Western blot analyses (Atkinson et a1. 1992; Chen et
a1. 1993). These recombinant proteins should be an
important source of antigens for large scale sero-
prevalence screening.
Studies on HIV have demonstrated that several
human herpesviruses, such as herpes simplex type 1
(Mosca et a1. 1987) and HHV-6 (Horvat et a1. 1989),
can be potential co-factors in HIV infection and the
interactions between HIV and these viruses have
been documented. BLV, BVDV, and BHV-1 are
common infections in cattle and cause great
economic losses to the cattle industry (Cockerell et
a1. 1992; Gibbs and Rweyemamu 1992; Xue et a1.
1990). Studies have demonstrated that BIV and
BHV-1 can interact in vitro, similar to what occurred
between HIV and human herpesvirus (Geng et a1.
1992). An investigation of BIV prevalence and its
relationship to other viral infections will provide
valuable information in understanding the patho-
genesis of BIV infection.
Cloning and Expression of
BIV Gag and Env Genes
BIV-infected animals develop strong antibody
responses to various structural proteins like the
capsid and the envelope glycoprotein. Antibodies
against p26 capsid protein developed earliest (22
days post-infection) and strongest (up to 38 months
post-infection) in calves that were experimentally
infected by BIV (Whetstone et a1. 1990). Therefore,
recombinant capsid and envelope proteins can be
used as an antigen source to detect animals infected
by BIV. The authors used the pATH (protein amend-
able for making tryptophan hybrid) expression vector
which uses the trp promoter to express the BIV gag
and env genes. The cloned genes can be expressed as
fusions to the trpE protein. The strategy centres on
cloning and expression in bacteria of defined regions
covering the entire gag and env coding regions using
restriction enzyme deletions of the viral genome. The
expressed proteins will then be tested for their
reactivities with bovine sera obtained from animals
that were infected by BIV. For the gag gene, six
different clones spanning various regions of the gag
open reading frame were generated (Fig. 1). These
recombinant proteins, especially gag-2, gag-3, gag-4,
and gag-5, can be expressed in high quantity and the
average yields of the fusion proteins were about
1 mg of 70-80% pure protein harvested from about
200 mL of bacteria. Analysis of the various express
gag proteins with a panel of immune bovine sera
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Figure 1. Summary of BIY gag constructs. Thick horizontal bars represent the relative genomic organisation of the gag, pol
and env coding regions of BIY. Large open box represents the unprocessed p53 gag precursor protein with nucleotide
positions given below in parentheses. Thin horizontal bars represent coding regions contained within each gag construct.
Numbers above in parentheses represent the nucleotide positions where specific restriction enzymes cut to generate the
specific construct.
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enabled identification of at least one major antigenic
determinant which can be recognised by all sera
tested. This determinant was encoded within the
47 kDa gag protein expressed by the gag-6 construct.
Similar strategy was used to generate nine dif-
ferent recombinant clones that span the various
regions of the BIV envelope open reading frame
(Fig. 2). These proteins were again expressed as
fusions to the trpE protein in E. coli. The levels of
these expressed proteins varied, some expressed at
large quantity that can be detected easily by SDS
polyacrylamide gel electrophoresis while others
cannot. The recombinant env protein that had the
strongest and most consistent reactiion with BIV-
infected bovine sera was the protein expressed by
env-8. This clone encodes a 134 amino acid peptide
that represents the amino terminal region of the
transmembrane domain of the envelope glycoprotein.
It is interesting that a major antigenic determinant of
HIV has also been mapped to a similar location on
the HIV-1 gp41 transmembrane glycoprotein (Wind-
heuser and Wood 1988).
Use of Recombinant Proteins to Screen for
BIV Seroprevalence
Accumulated serological screening data on BIV
seroprevalence in the USA showed a non-uniform
distribution (Gonda et a1. 1994). Very high sero-
prevalence was found in the southern United States,
e.g., Louisiana and Mississippi (Gonda 1992; St. Cyr
Coats et a1. 1994), while cattle in the eastern or
northern part of the USA are rarely positive. In
central USA states, such as Colorado, the sero-
prevalence rate was about 21%. These differences
ENV
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Figure 2. Schematic representation of various inserts of the pATH expression clones which cover most of BIV env ORF.
The solid line represents the insert of BIV env sequence cloned in frame with the trpE gene using the indicated restriction
enzyme sites. Their nucleotide positions are indicated according to the sequence published by Garvey et a1. (1990).
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could be due to differences in infection rate or due to
the different assays or the source of antigens used in
these studies. Because the recombinant BIY proteins
can detect BIY antibodies specifically, reproducibly
and are extremely sensitive, they were used to survey
for the seroprevalence of BIY in cattle from other
states in the central USA, such as Kansas. A
collection of 155 sera from different parts of Kansas
was tested with recombinant BIY gag protein in
Western blot assays. Out of the sera tested, 23 were
BIY positive (14.84%) (fable 1). The results are
consistent with what was observed previously with
the Colorado dairy herd based on an ELISA assay
(Cockerell et al. 1992).
herds in the northern part of China, 754 serum
samples were collected from different counties of
Zhangjiahou area (Table 3). Twenty-nine samples
were found to be positive by Western blot analysis,
and confirmed by PCR analyses. The 3-4% sero-
positive rate is similar to that reported in the south
and southwestern regions of the US. However, more
samples from various parts of China need to be
tested to determine if the seropositive rate varies, as
is the case in different geographical locations in the
US.
Table 2. Western blot analysis of BIV infection in Tianjin
area of China.
Table 1. Seroprevalence of BlV in Kansas cattle.
Although BIV infections have been reported in the
USA, in European countries, Australia and New
Zealand, the seroprevalence of BIY in some parts of
Asia and of China is not known. In recent years,
China has been importing both beef and dairy herds
from various European countries and the USA, so it
is possible that some of these imported cattle and
their progeny may be infected by BIY. It is also
possible that domestic herds in China may also be
infected by BIV. In order to determine the sero-
prevalence of BIV, recombinant gag and env pro-
teins were used in Western blot analyses to screen
several imported herds and their progeny in the
Tianjin area. In addition, domestic herds from
several northern provinces of China were also
screened. Positive samples were confirmed by PCR
analyses using primers that specifically amplify the
reverse transcriptase gene of BIV. The screening
results are shown in Tables 2 and 3. Of the 689
imported cattle screened from two separate areas, 16
were found to be positive by Western blot and PCR.
This represents a 2.32% seropositive rate. To further
study the seroprevalence of BIV in other domestic
Table 3. Serological survey of BlV in different parts of
Zhangjiahou area of China.
Area Testing Positive Positive
number number rate
Kangbao County 309 14 4.5%
Chabei Farm 21 2 9.5%
Chongli County 52 2 3.8%
Wei County 132 2 1.5%
Guyuan Farm 76 2 2.6%
Chicheng County 100 4 4.0%
Guyuan County 64 3 4.7%
Total 754 29 3.8%
Interaction between BIV and Bovine
Herpesvirus-l (BHV-1)
Numerous studies (Horvat et al. 1989) have demon-
strated that exogenous viral infection, such as human
herpesvirus, could be an important co-factor in HIV
activation and pathogenesis. It is also possible that
animal lentiviruses, like BIY, can also interact with
animal DNA viruses to playa role in pathogenesis.
These exogenous infections may also be responsible
for activation of BIY replication in infected animals.
In vitro studies have been conducted to determine the
possible interaction between BIV and BHV-l. BIY-
infected embryonic bovine lung (EBL) cells were
Total Positive Positive
number number rate %
tested
180 4 2.22
509 12 2.36
689 16 2.32Total
Progeny in Area A
Progeny in Area B
Origin of samples
1 (9.08%)
5 (20.8%)
4 (21.05%)
4 (13.33%)
0(0.00%)
1 (10.00%)
1 (25.00%)
5 (20.00%)
2 (7.69%)
23 (14.84%)
Number positive
(%)
11
24
19
30
6
10
4
25
26
155
Number tested
EI Dorado
Kansas City A
Kansas City B
Kansas City C
Kinsbury
Manhattan
Salina
Williamsburg
Other cities
Total
Town or cities
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superinfected with varying doses of BHV-1. Reverse
transcriptase (RT) in the culture supernatant was
measured to quantitate the levels of BIV expression.
Results showed that when BIV-EBL cells were
infected with BHV-l, RT activity was detected
earlier and at a higher level. The increase is pro-
portional to the amount of herpesviruses added,
indicating that there is an increase of BIV expression
when herpesviruses were present.
Similar activation of the HIV LTR has been
observed with HSV-l, and the IE gene products
ICPO and ICP4 have been demonstrated to mediate
such activations (Margolis et al. 1989). Because
BHV-l IE gene products BICPO and BICP4 share
homology with the HSV-1 IE gene products, tests
were conducted to determine if the BHV-1 IE gene
can transactivate BIV LTR-directed gene expression.
A p601 fragment was tested that encodes the
entire BHV-1 IE gene locus for activation of the
BIV-LTR (Fig. 3). When the BHV-l IE gene frag-
ment p601 was transfected into EBL in the presence
of BIV-CAT, only a very moderate (1.7 fold)
activation of the BIV LTR was observed. Since p601
fragment contains both BICPG and BICP4 open
reading frames, it is possible that they may affect the
transactivation function of each other. BICPO and
BICP4 were found to share a single promoter, and
the mRNAs are generated by differential splicing
(Wirth et a1. 1991). In order to distinguish their
effects on the BIV LTR, partial deletions were made
to generate several deletion clones of p601. The
p601-Dl has truncated the BICPO gene and p601-
D2 has truncation in the BICPO gene (Fig. 3). The
results indicated that only p601-D2, which contains
an intact BICPO gene, could significantly trans-
activate BIV LTR. It has thus been shown that the IE
gene product BICPO is a potent transactivator of co-
infecting viruses like BIV. Since very little is known
about the functions of BICPO, its transactivation of
the BIV promoter will provide a well-characterised
system to study the molecular mechanism involved
in BICPG transactivation, whether BICPG acts by
binding directly to a viral promoter, or indirectly via
other cellular factors.
Due to the in vitro interaction between BHV-l
and BIV, it will be important to determine the sero-
prevalence of BIV and BHV-l to determine whether
BIV infection could be associated with BHV-l
infection. This study was conducted with 155 serum
samples collected from the Kansas herds. In the
cases of BIV and BHV-1 antibody detections, 13 of
155 (8.93%) serum samples were both BHV-l and
BIV seropositive. Seventy-five of 155 (48.38%)
were BHV-1 seropositive while BIV negative.
Statistical results indicated that BHV-1 seroactivities
occurred independently of BIV infection (Table 4).
There was no association between BIV and BHV-l
(P>O.05 in both cases). The results indicate that BIV
infection did not clearly affect BHV-l prevalences
and BHV-l infections did not significantly change
the incidence of BIV infection. However, a larger
panel of serum samples from different geographical
locations should also be tested to determine the
relationship between BIV and BHV-1 infection.
~ I~1h UL IRSI IIHind. Xho I Sail Sty I Pst I Pst I EcoR I
IER2.9
< IIER2.6
Sail
p601-D1
EcoR I
EcoRIHind • Pst I Pst I
p601-D2 --------------------- --------------
Figure 3. The gene map and partial deletions of p601. Sequences retained in the truncated plasmids are represented by solid
lines. p601-Dl contains the complete ORF of IER4.2 (BICP4) and p601-D2 contains the complete ORF of IER2.9 (BICPO).
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BIV positive BIV negative Total
Table 4. Serological prevalance of BIV and BHV-l.
BHV-l positive 13 (8.39%) 75 (48.38%) 88 (56.77%)
BHV-l negative 10 (6.45%) 57 (36.77%) 667 (43.42%)
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